← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

OMI logoOwens & Minor, Inc.(OMI)Earnings, Financials & Key Ratios

OMI•NYSE
$2.24
$171M mkt cap·Price updated Apr 24, 2026
SectorHealthcareIndustryMedical DistributionSub-IndustryMedical and Surgical Supply Distribution
AboutOwens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.Show more
  • Revenue$2.76B-74.2%
  • EBITDA$123M+116.3%
  • Net Income-$1.1B-203.5%
  • EPS (Diluted)-14.24-201.1%
  • EBITDA Margin4.46%+738.0%
  • Operating Margin0.99%+151.2%
  • Net Margin-39.85%-1075.7%
  • ROE-2111.58%-4235.7%
  • ROIC1.84%+134.0%
  • Interest Coverage0.26+117.7%
Technical→

OMI Key Insights

Owens & Minor, Inc. (OMI) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Weak momentum: RS Rating 8 (bottom 8%)
  • ✗Sales declining 20.1% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

OMI Price & Volume

Owens & Minor, Inc. (OMI) stock price & volume — 10-year historical chart

Loading chart...

OMI Growth Metrics

Owens & Minor, Inc. (OMI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-11.87%
5 Years-20.1%
3 Years-34.78%
TTM-41%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-203.47%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM98.94%

Return on Capital

10 Years3.12%
5 Years3.94%
3 Years-0.9%
Last Year1.28%

OMI Recent Earnings

Owens & Minor, Inc. (OMI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (82%)●Beat Revenue 5/12 qtrs (50%)
Q1 2026Latest
Feb 27, 2026
EPS
$0.73
Est $0.22
-431.3%
Revenue
$1.2B
Q1 2026
Feb 20, 2026
EPS
$0.73
Revenue
$1.2B
Q4 2025
Oct 30, 2025
EPS
$0.25
Est $0.23
+8.7%
Revenue
$697M
Est $715M
-2.5%
Q3 2025
Aug 11, 2025
EPS
$0.26
Est $0.27
-3.7%
Revenue
$682M
Est $2.4B
-71.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 27, 2026
$0.73vs $0.22-431.3%
$1.2B
Q1 2026Feb 20, 2026
$0.73
$1.2B
Q4 2025Oct 30, 2025
$0.25vs $0.23+8.7%
$697Mvs $715M-2.5%
Q3 2025Aug 11, 2025
$0.26vs $0.27-3.7%
$682Mvs $2.4B-71.3%
Based on last 12 quarters of dataView full earnings history →

OMI Peer Comparison

Owens & Minor, Inc. (OMI) competitors in Medical and Surgical Supply Distribution — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
MCK logoMCKMcKesson CorporationDirect Competitor98.11B801.0131.1416.22%1.09%5.33%
CAH logoCAHCardinal Health, Inc.Direct Competitor46.36B197.0030.54-1.87%0.62%3.99%
HSIC logoHSICHenry Schein, Inc.Direct Competitor8.53B74.3722.744.03%3.02%8.24%6.71%0.77
MMSI logoMMSIMerit Medical Systems, Inc.Product Competitor3.61B60.4428.3811.66%9.03%8.95%5.98%0.57
AVNS logoAVNSAvanos Medical, Inc.Product Competitor1.15B24.70-16.921.95%-9.69%-8.91%3.74%0.17
NVCR logoNVCRNovoCure LimitedProduct Competitor1.81B15.88-13.028.28%-25.66%-50.82%0.85
SRDX logoSRDXSurmodics, Inc.Product Competitor614.51M42.98-52.41-4.91%-14.59%-15.59%0.28
ATRC logoATRCAtriCure, Inc.Product Competitor1.49B29.44-122.6714.88%-2.14%-2.43%3.24%0.18

Compare OMI vs Peers

Owens & Minor, Inc. (OMI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MCK

Most directly comparable listed peer for OMI.

Scale Benchmark

vs SYK

Larger-name benchmark to compare OMI against a more recognizable public peer.

Peer Set

Compare Top 5

vs MCK, CAH, HSIC, MMSI

OMI Income Statement

Owens & Minor, Inc. (OMI) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue9.32B9.84B9.21B8.48B9.79B9.96B10.33B10.7B2.76B
Revenue Growth %-4.17%5.59%-6.38%-7.93%15.39%1.74%3.8%3.55%-74.19%
Cost of Goods Sold8.15B8.47B8.08B7.2B8.27B8.13B8.21B8.48B0
COGS % of Revenue87.42%86.11%87.75%84.9%84.54%81.65%79.44%79.26%-
Gross Profit
1.17B▲ 0%
1.37B▲ 16.6%
1.13B▼ 17.4%
1.28B▲ 13.5%
1.51B▲ 18.1%
1.83B▲ 20.7%
2.13B▲ 16.4%
2.22B▲ 4.4%
0▼ 100.0%
Gross Margin %12.58%13.89%12.25%15.1%15.46%18.35%20.56%20.74%-
Gross Profit Growth %-1.3%16.65%-17.45%13.5%18.14%20.69%16.36%4.42%-100%
Operating Expenses1.02B1.26B1.06B1.08B1.14B1.68B2.02B2.43B1.07B
OpEx % of Revenue10.97%12.78%11.46%12.7%11.7%16.91%19.55%22.68%38.65%
Selling, General & Admin1.02B1.26B1.02B1.04B1.08B1.55B1.81B1.91B1.07B
SG&A % of Revenue10.91%12.82%11.12%12.3%11.01%15.62%17.55%17.85%38.65%
Research & Development000000000
R&D % of Revenue---------
Other Operating Expenses4.93M-4.42M30.67M34.05M67.69M128.62M207.09M517.13M0
Operating Income
89.25M▲ 0%
-392.17M▼ 539.4%
73.15M▲ 118.7%
204.12M▲ 179.0%
368.47M▲ 80.5%
142.91M▼ 61.2%
104.51M▼ 26.9%
-207.77M▼ 298.8%
27.46M▲ 113.2%
Operating Margin %0.96%-3.99%0.79%2.41%3.77%1.44%1.01%-1.94%0.99%
Operating Income Growth %-55.28%-539.41%118.65%179.04%80.52%-61.21%-26.87%-298.81%113.22%
EBITDA148.69M-308.77M160.6M287.25M459.09M371.58M391.88M57.01M123.29M
EBITDA Margin %1.6%-3.14%1.74%3.39%4.69%3.73%3.79%0.53%4.46%
EBITDA Growth %-41.69%-307.66%152.01%78.87%59.82%-19.06%5.46%-85.45%116.28%
D&A (Non-Cash Add-back)59.44M83.4M87.45M83.14M90.62M228.67M287.38M264.77M95.83M
EBIT149.96M-356.11M99.28M240.28M324.84M139.78M103.19M250.4M5.23M
Net Interest Income-31.77M-70.98M-98.11M-83.4M-48.09M-128.89M-157.91M-143.8M-107.18M
Interest Income000000000
Interest Expense31.77M70.98M98.11M83.4M48.09M128.89M157.91M143.8M107.18M
Other Income/Expense-31.77M-74.75M-101.87M-94.21M-91.72M-132.02M-159.23M-149.59M-129.41M
Pretax Income
57.48M▲ 0%
-469.19M▼ 916.3%
-28.72M▲ 93.9%
109.91M▲ 482.7%
276.75M▲ 151.8%
10.89M▼ 96.1%
-54.73M▼ 602.5%
-357.36M▼ 553.0%
-101.95M▲ 71.5%
Pretax Margin %0.62%-4.77%-0.31%1.3%2.83%0.11%-0.53%-3.34%-3.69%
Income Tax-15.31M-32.18M-6.13M21.83M55.16M-11.5M-13.43M5.33M729K
Effective Tax Rate %-26.64%6.86%21.36%19.87%19.93%-105.57%24.53%-1.49%-0.72%
Net Income
72.79M▲ 0%
-437.01M▼ 700.3%
-62.37M▲ 85.7%
29.87M▲ 147.9%
221.59M▲ 641.8%
22.39M▼ 89.9%
-41.3M▼ 284.5%
-362.69M▼ 778.2%
-1.1B▼ 203.5%
Net Margin %0.78%-4.44%-0.68%0.35%2.26%0.22%-0.4%-3.39%-39.85%
Net Income Growth %-33.09%-700.35%85.73%147.89%641.82%-89.9%-284.47%-778.15%-203.47%
Net Income (Continuing)72.79M-394.67M-22.58M88.07M221.59M22.39M-41.3M-362.69M-102.68M
Discontinued Operations00-39.79M-58.2M00000
Minority Interest000000000
EPS (Diluted)
1.20▲ 0%
-7.28▼ 706.7%
-0.37▲ 94.9%
0.47▲ 227.0%
2.94▲ 525.5%
0.29▼ 90.1%
-0.55▼ 289.7%
-4.73▼ 760.0%
-14.24▼ 201.1%
EPS Growth %-31.82%-706.67%94.92%227.03%525.53%-90.14%-289.66%-760%-201.06%
EPS (Basic)1.20-7.28-0.370.473.050.30-0.55-4.73-14.24
Diluted Shares Outstanding60M60.01M60.57M63.51M75.49M76.22M75.78M76.74M77.29M
Basic Shares Outstanding60M60.01M60.57M63.37M72.74M74.5M75.78M76.74M77.29M
Dividend Payout Ratio86.75%--2.17%0.33%----

OMI Balance Sheet

Owens & Minor, Inc. (OMI) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets2.18B2.54B2.41B2.14B2.32B2.3B2.1B2.02B547.87M
Cash & Short-Term Investments104.52M103.37M67.03M118.18M55.71M69.47M243.04M49.38M281.99M
Cash Only104.52M103.37M67.03M118.18M55.71M69.47M243.04M49.38M281.99M
Short-Term Investments000000000
Accounts Receivable758.94M756.69M674.71M700.79M681.56M763.5M598.26M690.24M95.91M
Days Sales Outstanding29.7328.0726.7430.1625.4227.9921.1323.5412.67
Inventory990.19M1.29B1.15B1.23B1.5B1.33B1.11B1.13B0
Days Inventory Outstanding44.3755.5851.7662.5566.0159.8849.3848.71-
Other Current Assets328.25M441.86M519.36M83.14M88.56M128.64M150.89M149.51M169.97M
Total Non-Current Assets1.19B1.24B1.24B1.2B1.21B3.09B2.99B2.63B1.9B
Property, Plant & Equipment206.49M386.72M457.65M460.42M511.24M858.93M840.5M864.97M0
Fixed Asset Turnover45.13x25.44x20.13x18.42x19.14x11.59x12.29x12.37x-
Goodwill713.81M414.12M393.18M394.09M390.19M1.64B1.64B1.33B1.23B
Intangible Assets184.47M321.76M285.02M281.35M243.75M483.74M361.83M296.73M136.47M
Long-Term Investments-74.25M-50.85M-40.55M16.32M16.32M15.46M8.45M6.11M0
Other Non-Current Assets89.62M112.6M99.96M47.6M53.24M96.26M149.35M134.04M539.28M
Total Assets
3.38B▲ 0%
3.77B▲ 11.8%
3.64B▼ 3.5%
3.34B▼ 8.4%
3.54B▲ 6.0%
5.39B▲ 52.3%
5.09B▼ 5.4%
4.66B▼ 8.6%
2.45B▼ 47.3%
Asset Turnover2.76x2.61x2.53x2.54x2.77x1.85x2.03x2.30x1.13x
Asset Growth %24.23%11.77%-3.46%-8.44%6.02%52.3%-5.44%-8.58%-47.34%
Total Current Liabilities1.31B1.47B1.42B1.35B1.34B1.57B1.89B1.87B947.08M
Accounts Payable947.57M1.07B808.03M1B1B1.15B1.17B1.25B363.56M
Days Payables Outstanding42.4645.8936.4950.7144.2151.5252.1153.88-
Short-Term Debt028.69M50.22M34.5M43.85M15.38M204.08M40M250M
Deferred Revenue (Current)0-28.69M40.55M000116.4M00
Other Current Liabilities203.36M336.36M427.26M201.6M182.35M227.44M191.66M425.54M333.51M
Current Ratio1.67x1.72x1.70x1.59x1.73x1.47x1.11x1.08x0.58x
Quick Ratio0.91x0.85x0.89x0.67x0.61x0.61x0.52x0.47x0.58x
Cash Conversion Cycle31.6437.7642.014247.2236.3518.4118.38-
Total Non-Current Liabilities1.05B1.78B1.76B1.28B1.25B2.87B2.28B2.22B1.97B
Long-Term Debt900.74M1.65B1.51B975.89M936.23M2.47B1.88B1.8B70.32M
Capital Lease Obligations00117.08M130.06M173.56M227.35M231.99M295.49M0
Deferred Tax Liabilities74.25M50.85M40.55M50.64M35.31M041.65M22.46M0
Other Non-Current Liabilities76.09M81.92M98.73M121.27M108.94M175.78M122.59M100.13M1.9B
Total Liabilities2.36B3.26B3.18B2.62B2.6B4.44B4.17B4.09B2.91B
Total Debt900.74M1.65B1.71B1.14B1.15B2.79B2.41B2.14B320.32M
Net Debt796.22M1.55B1.64B1.02B1.1B2.72B2.16B2.09B38.33M
Debt / Equity0.89x3.18x3.70x1.60x1.23x2.95x2.60x3.79x-
Debt / EBITDA6.06x-10.64x3.97x2.51x7.52x6.14x37.54x2.60x
Net Debt / EBITDA5.35x-10.22x3.56x2.39x7.33x5.52x36.67x0.31x
Interest Coverage2.81x-5.52x0.75x2.45x7.66x1.11x0.66x-1.44x0.26x
Total Equity
1.02B▲ 0%
518.42M▼ 48.9%
462.15M▼ 10.9%
712.05M▲ 54.1%
938.5M▲ 31.8%
945.6M▲ 0.8%
924.17M▼ 2.3%
565.23M▼ 38.8%
-460.98M▼ 181.6%
Equity Growth %5.77%-48.95%-10.85%54.07%31.8%0.76%-2.27%-38.84%-181.56%
Book Value per Share16.928.647.6311.2112.4312.4112.197.37-5.96
Total Shareholders' Equity1.02B518.42M462.15M712.05M938.5M945.6M924.17M565.23M-460.98M
Common Stock122.95M124.59M125.69M146.94M150.87M152.56M153.09M154.4M0
Retained Earnings690.67M200.67M137.77M167.02M387.62M410.01M368.71M6.02M0
Treasury Stock000000000
Accumulated OCI-25.08M-45.61M-52.71M-38.51M-40.59M-35.85M-31.82M-49.34M0
Minority Interest000000000

OMI Cash Flow Statement

Owens & Minor, Inc. (OMI) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations56.77M115.59M166.09M339.22M124.18M325.01M740.71M161.5M0
Operating CF Margin %0.61%1.17%1.8%4%1.27%3.26%7.17%1.51%-
Operating CF Growth %-69.63%103.59%43.69%104.25%-63.39%161.73%127.91%-78.2%-100%
Net Income72.79M-437.01M-62.37M29.87M221.59M22.39M-41.3M-362.69M-102.68M
Depreciation & Amortization59.44M101.93M116.68M93.34M90.62M228.67M287.38M264.77M95.83M
Stock-Based Compensation11.91M16.38M15.8M20.01M25.02M20.99M23.22M26.84M12M
Deferred Taxes-49.99M-35.02M-17.4M15.56M-29.74M-26.36M-23.65M-26.11M0
Other Non-Cash Items8.97M455.09M52.76M101.9M78.09M-10.45M-27.22M284.12M-5.15M
Working Capital Changes-46.36M14.23M60.62M78.55M-261.4M89.77M522.29M-25.44M0
Change in Receivables-100.01M11.11M63.53M-34.82M-2.2M1.1M166.58M-94.55M0
Change in Inventory-57.03M-65.45M127.92M-85.15M-263.44M166.56M224.34M-26.23M0
Change in Payables143.95M92.18M-235.63M193.24M3.55M13.65M31M65.19M0
Cash from Investing-416.64M-815.83M-51.9M80.07M-53.63M-1.8B-137.25M-116.53M0
Capital Expenditures-50.74M-65.69M-42.42M-50.42M-49.69M-166.58M-190.87M-210.87M0
CapEx % of Revenue0.54%0.67%0.46%0.59%0.51%1.67%1.85%1.97%-
Acquisitions-366.57M-751.83M0133M-43.37M-1.68B000
Investments---------
Other Investing663K1.69M-9.48M-2.5M39.43M46.71M53.62M94.33M0
Cash from Financing272.81M701.07M-130.2M-379.39M-129.48M1.5B-417.33M-267.6M0
Debt Issued (Net)351.48M785M-117.79M-541.85M-95.35M1.58B-416.69M-244.2M0
Equity Issued (Net)-1000K001000K00000
Dividends Paid-63.15M-48.2M-5.23M-648K-731K0000
Share Repurchases-5M00000000
Other Financing-10.52M-35.73M-7.18M-26.86M-33.4M-85.39M-637K-23.41M0
Net Change in Cash
-80.97M▲ 0%
-1.16M▲ 98.6%
-18.68M▼ 1517.3%
49.82M▲ 366.7%
-62.47M▼ 225.4%
14.15M▲ 122.7%
186.74M▲ 1219.7%
-223.54M▼ 219.7%
0▲ 100.0%
Free Cash Flow
6.04M▲ 0%
49.9M▲ 726.6%
113.86M▲ 128.2%
280.03M▲ 145.9%
74.49M▼ 73.4%
158.42M▲ 112.7%
532.82M▲ 236.3%
-66.67M▼ 112.5%
0▲ 100.0%
FCF Margin %0.06%0.51%1.24%3.3%0.76%1.59%5.16%-0.62%-
FCF Growth %-96.15%726.64%128.15%145.95%-73.4%112.69%236.32%-112.51%100%
FCF per Share0.100.831.884.410.992.087.03-0.87-
FCF Conversion (FCF/Net Income)0.78x-0.26x-2.66x11.36x0.56x14.52x-17.93x-0.45x-
Interest Paid068.58M95.41M89.96M38.72M107.02M153.25M141.55M0
Taxes Paid019.15M6.2M17.45M99.4M33.97M6.28M5.55M0

OMI Key Ratios

Owens & Minor, Inc. (OMI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)11.14%7.37%-56.98%-12.72%5.09%26.85%2.38%-4.42%-48.7%-2111.58%
Return on Invested Capital (ROIC)10.91%4.25%-15.17%2.63%7.98%14.66%3.76%2.32%-5.43%1.84%
Gross Margin12.21%12.58%13.89%12.25%15.1%15.46%18.35%20.56%20.74%-
Net Margin1.12%0.78%-4.44%-0.68%0.35%2.26%0.22%-0.4%-3.39%-39.85%
Debt / Equity0.59x0.89x3.18x3.70x1.60x1.23x2.95x2.60x3.79x-
Interest Coverage7.38x2.81x-5.52x0.75x2.45x7.66x1.11x0.66x-1.44x0.26x
FCF Conversion1.72x0.78x-0.26x-2.66x11.36x0.56x14.52x-17.93x-0.45x-
Revenue Growth-0.51%-4.17%5.59%-6.38%-7.93%15.39%1.74%3.8%3.55%-74.19%

OMI SEC Filings & Documents

Owens & Minor, Inc. (OMI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Feb 19, 2026·SEC

Material company update

Dec 31, 2025·SEC

Material company update

Dec 18, 2025·SEC

10-K Annual Reports

3
FY 2026

Feb 20, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 20, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 11, 2025·SEC

FY 2025

May 8, 2025·SEC

OMI Frequently Asked Questions

Owens & Minor, Inc. (OMI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Owens & Minor, Inc. (OMI) reported $2.76B in revenue for fiscal year 2025. This represents a 9% decrease from $3.02B in 1996.

Owens & Minor, Inc. (OMI) saw revenue decline by 74.2% over the past year.

Owens & Minor, Inc. (OMI) reported a net loss of $1.10B for fiscal year 2025.

Dividend & Returns

Owens & Minor, Inc. (OMI) has a return on equity (ROE) of -2111.6%. Negative ROE indicates the company is unprofitable.

Owens & Minor, Inc. (OMI) had negative free cash flow of $352.8M in fiscal year 2025, likely due to heavy capital investments.

Explore More OMI

Owens & Minor, Inc. (OMI) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.